Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apomorphine injections and pump therapy in Iraqi patients with Parkinson's disease
PACTR202605760621936Phase 4Recruiting
- Sponsor
- College of Medicine, University of Baghdad
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of apomorphine in Parkinson's disease (PD), sponsored by College of Medicine, University of Baghdad. Primary endpoints: Decrease in off hours and Reduce use of oral medication. Started Jun 2026; status: recruiting.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on PACTR202605760621936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202605760621936.